Crescent Biopharma, Inc.
CBIO
$10.29
-$0.06-0.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 213.19M | 133.27M | 152.65M | ||
| Total Receivables | 18.00M | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 5.46M | 1.30M | 1.58M | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 236.66M | 134.56M | 154.23M | ||
|
|
|||||
| Total Current Assets | 236.66M | 134.56M | 154.23M | ||
| Net Property, Plant & Equipment | 2.32M | 2.35M | 1.80M | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 1.32M | 1.36M | 1.41M | ||
| Total Assets | 240.29M | 138.27M | 157.43M | ||
|
|
|||||
| Total Accounts Payable | 10.00M | 2.56M | 1.65M | ||
| Total Accrued Expenses | 16.48M | 15.24M | 12.79M | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 435.00K | 417.00K | 211.00K | ||
| Total Finance Division Other Current Liabilities | 9.16M | 2.09M | 2.10M | ||
| Total Other Current Liabilities | 9.16M | 2.09M | 2.10M | ||
| Total Current Liabilities | 36.07M | 20.30M | 16.75M | ||
|
|
|||||
| Total Current Liabilities | 36.07M | 20.30M | 16.75M | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 1.21M | 1.32M | 1.43M | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 37.28M | 21.63M | 18.18M | ||
|
|
|||||
| Common Stock & APIC | 370.82M | 192.05M | 190.06M | ||
| Retained Earnings | -171.81M | -79.41M | -54.81M | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 199.01M | 112.64M | 135.25M | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | 4.00M | 4.00M | 4.00M | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | 4.00M | 4.00M | 4.00M | ||
|
|
|||||
| Total Common Equity | 199.01M | 112.64M | 135.25M | ||
| Total Preferred Equity | 4.00M | 4.00M | 4.00M | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 203.01M | 116.64M | 139.25M | ||
|
|
|||||